Sometimes we honestly believe that Momma Kliff is an angle on our shoulder. Who else could have set up this combination as per a story posted by Drug Delivery;
“Innovation Health and Sanofi (NYSE: SNY) said today that the companies are launching a pilot program to evaluate the impact of digital health solutions from One Drop and Common Sensing for people with Type II diabetes.
The program hopes to enable pharmaceutical companies, tech companies and plan providers to work together to improve patient outcomes, according to Innovation Health.”
Think about this just for a moment as for us this is . . .
This content is restricted to subscribers. Please subscribe.
Already have an account? Please login.